Nadjia Hamlat
Nadjia Hamlat has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adel Benarfa
Centre de Recherche Scientifique Et Technique en Analyses Physico-Chimiques (CRAPC)-PTAPC, P.O. Box 0354, Laghouat 03000, Algeria
1 shared publication - Aicha Hassani
Ecole Normale Supérieure , Algeria
1 shared publication - Alia Khwaldeh
Department of Medical Laboratory Sciences, Faculty of Pharmacy , Jadara University , Jordan
1 shared publication - Barbara Sawicka
Department of Plant Production Technology and Commodity Sciences, University of Life Sciences, 20-950 Lublin, Poland
1 shared publication - Fatma U. Afifi
Department of Pharmaceutical Sciences, Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan
1 shared publication - Hussam Mizher
Department of Basic Medical Science, Kulliyyah of Pharmacy, Centre for Natural and Health Sciences, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Kuantan, Pahang, Malaysia
1 shared publication
Latest Publications
- Open Access
- 1 September 2024
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 37 (3) , 131-137
Dual amylase/glucosidase inhibition, antilipolytic and antiproliferative potential of the aerial parts of Pistacia atlantica, Pistacia lentiscus and Pistacia terebinthus on a obesity related-colorectal cancer cell line panel
Pistacia species (P. spp) have been used as a treatment for various diseases, including diabetes and inflammation. This study aimed to identify the main components of flavonoids in Pistacia species and evaluate the effect of aqueous extracts of P. spp on pancreatic enzymes and on cancer cells associated with obesity in colon and rectum. HPLC was used to identify the major components of flavonoids. The potent inhibitory effect of Pistacia species against pancreatic α-amylase, α-glucosidase and lipase was examined. The antiproliferative efficacy of the plant extract against several colorectal cancer cell lines were then measured. The main flavonoids component found in Pistacia species are quercetin-3-β-D-glucoside, rutin, kaempferol and vitexin. The starch blockade IC50 (µg/mL) of Pistacia species in a descending order were: P. lentiscus leaves: 1.09±0.01; P. atlantica leaves: 0.96±0.09 and P. atlantica fruits: 0.48±0.02. Pistacia species exerted promising inhibition effect for pancreatic lipase (PL). Besides the aglycones of P. atlantica leaves, all the tested aqueous extracts exerted appreciably novel antiproliferative activity against the tested colorectal cancer cell lines. This study provides useful indication for the Pistacia species as a potential novel therapeutic agent against diabesity and cancer.
- 1 September 2024
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 37 (3) , 131-137
Open AccessDual amylase/glucosidase inhibition, antilipolytic and antiproliferative potential of the aerial parts of Pistacia atlantica, Pistacia lentiscus and Pistacia terebinthus on a obesity related-colorectal cancer cell line panel
Pistacia species (P. spp) have been used as a treatment for various diseases, including diabetes and inflammation. This study aimed to identify the main components of flavonoids in Pistacia species and evaluate the effect of aqueous extracts of P. spp on pancreatic enzymes and on cancer cells associated with obesity in colon and rectum. HPLC was used to identify the major components of flavonoids. The potent inhibitory effect of Pistacia species against pancreatic α-amylase, α-glucosidase and lipase was examined. The antiproliferative efficacy of the plant extract against several colorectal cancer cell lines were then measured. The main flavonoids component found in Pistacia species are quercetin-3-β-D-glucoside, rutin, kaempferol and vitexin. The starch blockade IC50 (µg/mL) of Pistacia species in a descending order were: P. lentiscus leaves: 1.09±0.01; P. atlantica leaves: 0.96±0.09 and P. atlantica fruits: 0.48±0.02. Pistacia species exerted promising inhibition effect for pancreatic lipase (PL). Besides the aglycones of P. atlantica leaves, all the tested aqueous extracts exerted appreciably novel antiproliferative activity against the tested colorectal cancer cell lines. This study provides useful indication for the Pistacia species as a potential novel therapeutic agent against diabesity and cancer.
- 13 July 2020
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (10) , 821-828
Elemental composition analysis of Pistacia lentiscus L., leaves collected from Mitidja plain in Algeria using instrumental neutron activation analysis (INAA) technique
Most of the rural Algerian communities believed that Pistacia lentiscus L. leaves have therapeutic capacities to treat many gastric diseases and abdomen aches, whereas, the rural habitants of Mitidja, Algeria powdered P. lentiscus L. leaves and consume it fresh in order to heal mild dyspeptic disorders and peptic ulcer. Therefore, the current study was conducted to investigate and monitor the amount of essential and toxic elements of these leaves. The leaf samples were collected from a place called Mitidja, Algeria in autumn 2014. Thereafter, those samples were subjected to an instrumental neutron activation analysis (INAA). Fourteen elements were assessed (As, Br, Ca, Co, Fe, K, La, Na, Rb, Sb, Sc, Sm, Th and Zn). Where, the elements Ca, Fe, K, Na and Zn presented significant concentrations. On the other hand, it was found that the tolerable daily intake (TDI) of these leaves for an adult person per day, is with the tolerance limits and satisfy the nutritional references. Moreover, P. lentiscus L. leaves might be an important nature supplier source of Ca, K, Na, Fe and Zn for the human body, since these elements are considered as the most dietary supplements recommended by doctors to maintain good health.
- 13 July 2020
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (10) , 821-828
Elemental composition analysis of Pistacia lentiscus L., leaves collected from Mitidja plain in Algeria using instrumental neutron activation analysis (INAA) technique
Most of the rural Algerian communities believed that Pistacia lentiscus L. leaves have therapeutic capacities to treat many gastric diseases and abdomen aches, whereas, the rural habitants of Mitidja, Algeria powdered P. lentiscus L. leaves and consume it fresh in order to heal mild dyspeptic disorders and peptic ulcer. Therefore, the current study was conducted to investigate and monitor the amount of essential and toxic elements of these leaves. The leaf samples were collected from a place called Mitidja, Algeria in autumn 2014. Thereafter, those samples were subjected to an instrumental neutron activation analysis (INAA). Fourteen elements were assessed (As, Br, Ca, Co, Fe, K, La, Na, Rb, Sb, Sc, Sm, Th and Zn). Where, the elements Ca, Fe, K, Na and Zn presented significant concentrations. On the other hand, it was found that the tolerable daily intake (TDI) of these leaves for an adult person per day, is with the tolerance limits and satisfy the nutritional references. Moreover, P. lentiscus L. leaves might be an important nature supplier source of Ca, K, Na, Fe and Zn for the human body, since these elements are considered as the most dietary supplements recommended by doctors to maintain good health.